Tuftsin: An Immunomodulating Peptide Hormone and Its Clinical Potential as a Natural Biological Response Modifier

References

• James K, McBride B, Stuart A. The Macrophage and Cancer. University of Edinburgh, Edinburgh 1977
   Google Scholar
• Haberman R B. Natural Cell-Mediated Immunity Against Tumors. Academic Press, New York 1980
   Google Scholar
• Klebanoff S J, Clark R A. The Neutrophil: Function and Clinical Disorders. North-Holland Publishing Co, New York 1978
   Google Scholar
• Chirigos M A. Immune Modulation and Control of Neoplasia by Adjuvant Therapy. Raven Press, New York 1978
   Google Scholar
• Hersh E M, Chirigos M A, Mastrangelo M J. Augmenting Agents in Cancer Therapy. Raven Press, New York 1981
   Google Scholar
• Oldham R K. Biological response modifiers program. J Biol Resp Modif 1982; 1: 81–100
   Google Scholar
• Nishioka K, Amoscato A A, Babcock G F. Minireview: Tuftsin: A hormone-like tetrapeptide with antimicrobial and antitumor activities. Life Sci 1981; 28: 1081–1090
   PubMedGoogle Scholar
• Goldstein A L, Low T LK, Thurman G B, Zatz M M, Hall N, Chen J, Hu S-K, Naylor P B, McClure J E. Current status of thymosin and other hormones of the thymus gland. Recent Progress in Hormone Research, R O Greep. Academic Press, New York 1981; Vol 37: 369–415
   Google Scholar
• Pestka S. The human interferons-From protein purification and sequence to cloning and expression in bacteria: Before, between, and beyond. Arch Biochem Biophys 1983; 221: 1–37
   PubMed Web of Science ®Google Scholar
• Najjar V A, Nishioka K. 'Tuftsin': A physiological phagocytosis stimulating peptide. Nature (London) 1970; 228: 672–673
   PubMed Web of Science ®Google Scholar
• Najjar V A, Fidalgo B V, Stitt E. The physiological role of the lymphoid system. VII. The disappearance of leucokinin activity following splenectomy. Biochemistry 1968; 7: 2376–2379
   PubMed Web of Science ®Google Scholar
• Nishioka K, Constantopoulos A, Statoh P S, Najjar V A. The characteristics, isolation and synthesis of the phagocytosis stimulating peptide tuftsin. Biochem Biophys Res Commun 1972; 47: 172–179
   PubMed Web of Science ®Google Scholar
• Nishioka K, Constantopoulos A, Satoh P S, Mitchell W M, Najjar V A. Characteristics and isolation of the phagocytosis-stimulating peptide tuftsin. Biochim Biophys Acta 1973; 310: 217–229
   PubMed Web of Science ®Google Scholar
• Nishioka K, Satoh P S, Constantopoulos A, Najjar V A. The chemical synthesis of the phagocytosis-stimulating tetrapeptide tuftsin (Thr-Lys-Pro-Arg) and its biological properties. Biochim Biophys Acta 1973; 310: 230–237
   PubMed Web of Science ®Google Scholar
• Edelman G F, Cunningham B A, Gall W E, Gottlieb P D, Rutishauser U, Waxdal M J. The covalent structure of an entire γG immunoglobulin molecule. Proc Natl Acad Sci USA 1969; 63: 78–85
   PubMed Web of Science ®Google Scholar
• Najjar V A, Constantopoulos A. A new phagocytosis-stimulating tetrapeptide hormone, tuftsin, and its role in disease. J Reticuloendothel Soc 1972; 12: 197–215
   PubMedGoogle Scholar
• Constantopoulos A, Najjar V A. Tuftsin deficiency syndrome. Acta Paediatr Scand 1973; 62: 645–648
   PubMed Web of Science ®Google Scholar
• Inada K, Nemoto N, Nishijima A, Wada S, Hirata M, Yoshida M. A suspected case of tuftsin deficiency. Phagocytosis: Its Physiology and Pathology, Y Kokubun, N Kobayashi. University Park Press, Baltimore 1979; 101–108
   Google Scholar
• Najjar V A, Chaudhuri M K, Konopinska D, Beck B D, Layne P P, Linehan L. Tuftsin (Thr-Lys-Pro-Arg) a physiological activator of phagocytic cells: A possible role in cancer suppression and therapy. Augmenting Agents of Cancer Therapy, E M Hersh, A Ghirigos, M Mastrangelo. Raven Press, New York 1980; 459–478
   Google Scholar
• Konopinska D, Najjar V A, Callery M. Solid phase synthesis of L-threonyl-L-glutamyl-L-prolyl-L-arginine, as the mutant analog of tuftsin. Arch Immunol Ther Exp 1981; 29: 851–856
   PubMed Web of Science ®Google Scholar
• Likhite V V. Opsonin and leucophilic γ-globulin in chronically splenectomized rat with and without heterotropic auto-transplanted splenic tissue. Nature (London) 1975; 253: 742–744
   PubMed Web of Science ®Google Scholar
• Spirer Z, Zakuth V, Bogair N, Fridkin M. Radioimmunoassay of the phagocytosis-stimulating peptide tuftsin in normal and splenectomized subjects. Eur J Immunol 1977; 7: 69–74
   PubMed Web of Science ®Google Scholar
• Pearson H A, Johnston D, Smith K A, Touloukian R J. The born-again spleen: Return of splenic function after splenectomy for trauma. N Engl J Med 1978; 298: 1389–1392
   PubMed Web of Science ®Google Scholar
• Singer D B. Postsplenectomy sepsis. Perspect Pediatr Pathol 1973; 1: 285–305
   PubMedGoogle Scholar
• Balfanz J R, Nesbit M E, Jr, Jarvis C, Krivit W. Overwhelming sepsis following splenectomy for trauma. J Pediatr 1976; 88: 458–460
   PubMed Web of Science ®Google Scholar
• Aigner K, Dobroschke J, Weber E G, Schwemmle K, Bauer M, Teuber J, Helmke K. Successful reimplantation of splenic tissue after neonatal abdominal trauma. Lancet 1980; 1: 360–361
   PubMed Web of Science ®Google Scholar
• Patel J, Williams J S, Shmigel B, Hinshaw R. Preservation of splenic function by autotransplantation of traumatized spleen in man. Surgery 1981; 90: 683–688
   PubMed Web of Science ®Google Scholar
• Millikan J S, Moore E E, Moore G E, Stevens R E. Alternative to splenectomy in adults after trauma, repair, partial resection, and reimplantation of splenic tissue. Am J Surgery 1982; 144: 711–716
   PubMed Web of Science ®Google Scholar
• Constantopoulos A, Likhite V, Crosby W H, Najjar V A. Phagocytic activity of the leukemic cells and its response to the phagocytosis-stimulating tetrapeptide, tuftsin. Cancer Res 1973; 33: 1230–1234
   PubMed Web of Science ®Google Scholar
• Spirer Z, Weisman Y, Zakuth V, Fridkin M, Bogair N. Decreased serum tuftsin concentrations in sickle cell disease. Arch Dis Child 1980; 55: 566–567
   PubMed Web of Science ®Google Scholar
• Fridkin M, Gottlieb P. Tuftsin, Thr-Lys-Pro-Arg: Anatomy of an immunologically active peptide. Mol Cell Biochem 1981; 41: 73–97
   PubMed Web of Science ®Google Scholar
• Siemion I Z, Konopinska D. Tuftsin analogs and their biological activity. Mol Cell Biochem 1981; 41: 13–18
   PubMedGoogle Scholar
• Amoscato A A, Babcock G F, Nishioka K. Analysis of contaminants in commercial preparations of the tetrapeptide tuftsin by high-performance liquid chromatography. J Chromatogr 1981; 205: 179–184
   PubMed Web of Science ®Google Scholar
• Constantopoulos A, Najjar V A. The requirement for membrane sialic acid in the stimulation of phagocytosis by the natural tetrapeptide, tuftsin. J Biol Chem 1973; 248: 3819–3822
   PubMed Web of Science ®Google Scholar
• Stabinsky Y, Gottlieb P, Zakuth V, Spirer Z, Fridkin M. Specific binding sites for the phagocytosis stimulating peptide tuftsin on human polymorphonuclear leukcocytes and monocytes. Biochem Biophys Res Commun 1978; 83: 599–606
   PubMed Web of Science ®Google Scholar
• Nair R MG, Ponce B, Fudenberg H H. Interactions of radiolabeled tuftsin with human neutrophils. Immunochemistry 1978; 15: 901–907
   PubMedGoogle Scholar
• Bar-Shavit Z, Stabinsky Y, Fridkin M, Goldman R. Tuftsin-macrophage interaction: Specific binding and augmentation of phagocytosis. J Cell Physiol 1979; 100: 55–62
   PubMed Web of Science ®Google Scholar
• Constantopoulos A, Najjar V A. Tuftsin, a natural and general phagocytosis stimulating peptide affecting macrophages and polymorphonuclear granulocytes. Cytobios 1972; 6: 97–100
   Google Scholar
• Bar-Shavit Z, Bursuker I, Goldman R. Functional tuftsin binding sites on macrophage-like tumor line P388D1 and on bone marrow cells differentiated in vitro into mononuclear phagocytes. Mol Cell Biochem 1980; 30: 151–155
   PubMed Web of Science ®Google Scholar
• Amoscato A A, Davies P JA, Babcock G F, Nishioka K. Receptor-mediated internalization of tuftsin by human polymorphonuclear leukocytes. J Reticuloendothel Soc 1983; 34: 53–67
   PubMedGoogle Scholar
• Amoscato A A, Davies P JA, Babcock G F, Nishioka K. Receptor-mediated internalization of tuftsin. Ann NY Acad Sci, in press
   Google Scholar
• Middlebrook J L, Kohn L D. Receptor-Mediated Binding and Internalized of Toxins and Hormones. Academic Press, New York 1981
   Google Scholar
• Goldstein J L, Anderson R OW, Brown M S. Coated pits, coated vesicles, and recepter-mediated endocytosis. Nature (London) 1979; 279: 679–685
   PubMed Web of Science ®Google Scholar
• Niedel J E, Kahane I, Cuatrecasas P. Receptor-mediated internalization of fluorescent chemotactic peptide by human neutrophils. Science 1979; 205: 1412–1414
   PubMed Web of Science ®Google Scholar
• Blumenstein M, Layne P P, Najjar V A. Nuclear magnetic resonance studies on the structure of the tetrapeptide tuftsin, L-threonyl-L-lysyl-L-prolyl-L-arginine, and its pentapeptide analogue L-threonyl-L-lysyl-L-prolyl-L-prolyl-L-arginine. Biochem 1979; 18: 5247–5253
   PubMed Web of Science ®Google Scholar
• Spirer Z, Zakuth V, Golander A, Bogair N, Fridkin M. The effect of tuftsin on the nitrous blue tetrazolium reduction of normal human polymorphonuclear leukocytes. J Clin Invest 1975; 55: 198–200
   PubMed Web of Science ®Google Scholar
• Tritsch G L, Niswander P W. Positive correlation between superoxide release and intracellular adenosine deaminase activity during macrophage membrane perturbation regardless of nature or magnitude of stimulus. Mol Cell Biochem 1982; 49: 49–51
   PubMed Web of Science ®Google Scholar
• Hartung H P, Toyka K V. Tuftsin stimulates the release of oxygen radicals and thromboxane from macrophages. Immunol Lett 1983; 6: 1–6
   PubMed Web of Science ®Google Scholar
• Stabinsky Y, Bar-Shavit Z, Fridkin M, Goldman R. On the mechanism of action of the phagocytosis-stimulating peptide tuftsin. Mol Cell Biochem 1980; 30: 71–77
   PubMed Web of Science ®Google Scholar
• Rauner R A, Schmidt J J, Najjar V A. Proline endopeptidase and exopeptidase activity in polymorphonuclear granulocytes. Mol Cell Biochem 1976; 10: 77–80
   PubMed Web of Science ®Google Scholar
• Nagaoka I, Yamashita T. Inactivation of phagocytosis-stimulating activity of tuftsin by polymorphonuclear neutrophils: A possible role of leucine aminopeptidase as an ecto-enzyme. Biochim Biophys Acta 1981; 675: 85–93
   PubMed Web of Science ®Google Scholar
• Phillips J H, Babcock G F, Nishioka K. Tuftsin: A naturally occurring immunopotentiating factor I. In vitro enhancement of murine natural cell-mediated cytotoxicity. J Immunol 1981; 126: 915–921
   PubMed Web of Science ®Google Scholar
• Martinez J, Winternitz F, Videl J. Nouvelles syntheses et proprietes de la tuftsine. Eur J Med Chem Chim Ther 1977; 12: 511–516
   Web of Science ®Google Scholar
• Franke E L, Neu H C. Postsplenectomy infection. Surg Clin North Am 1981; 61: 135–155
   PubMed Web of Science ®Google Scholar
• Chilcote R R, Baehner R L, Hammond D. Septicemia and meningitis in children splenectomized for Hodgkin's disease. N Engl J Med 1976; 295: 798–800
   PubMed Web of Science ®Google Scholar
• Rosner F, Zarrabi M H. Late infections following splenectomy in Hodgkin's disease. Cancer Invest 1983; 1: 57–65
   PubMed Web of Science ®Google Scholar
• Mikulski S M, Von Hoff D D, Rozencweig M, Muggia F M. Tuftsin—Unimportant or forgotten?. N Engl J Med 1977; 296: 454
   PubMed Web of Science ®Google Scholar
• Hisatsune K, Nozaki S, Ishikawa T, Hayashi M, Nagaki K, Ogawa H. Biochemical study of phagocytic activities of tuftsin and its analogues. Ann NY Acad Sci, in press
   PubMed Web of Science ®Google Scholar
• Nishioka K. Anti-tumor effect of the physiological tetrapeptide, tuftsin. Br J Cancer 1979; 39: 342–345
   PubMed Web of Science ®Google Scholar
• Nishioka K. Migration enhancement by tuftsin of human mononuclear cells and its effect on the migration inhibition factor test with tumor antigens. Gann 1978; 69: 569–572
   PubMedGoogle Scholar
• Babcock G F, Amoscato A A, Nishioka K. Effect of tuftsin on the migration, chemotaxis and differentiation of macrophages and granulocytes. Ann NY Acad Sci, in press
   Web of Science ®Google Scholar
• Goetzl E J. Plasma and cell-derived inhibitors of human neutrophil chemotaxis. Ann NY Acad Sci 1975; 256: 210–221
   PubMed Web of Science ®Google Scholar
• Goetzl E J. Modulation of human eosinophil polymorphonuclear leukocyte migration and function. Am J Pathol 1976; 85: 419–435
   PubMed Web of Science ®Google Scholar
• Horsmanheimo A, Horsmanheimo M, Fudenberg H H. Effect of tuftsin on migration of polymorphonuclear and mononuclear human leukocytes in leukocyte migration agarose test. Clin Immunol Immunopathol 1978; 11: 251–255
   PubMedGoogle Scholar
• Yamanaka N, Fukushima M, Matsuoka H, Nishida K, Ota K. Effect of tuftsin on polymorphonuclear leukocyte metabolism. Phagocytosis: Its Physiology and Pathology, Y Kokubun, N Kobayashi. University Park Press, Baltimore 1979; 93–100
   Google Scholar
• Giroud J P, Roch-Arveiller M, Muntaner O, Bradshaw D. Action comparee et de la tuftsine sur le chimiotactisme des polynucleaires de rat. Nouv Rev Fr Hematol 1980; 22: 69–76
   Google Scholar
• Kavai M, Lukacs K, Szegedi G, Szekerke M, Erchegyi J. Chemotactic and stimulating effect of tuftsin and its analogues en human monycytes. Immunol Lett 1981; 2: 219–224
   Web of Science ®Google Scholar
• Florentin I, Bruley-Rosset M, Kiger N, Imbach J L, Winternitz F, Mathe G. In vivo immunostimulation by tuftsin. Cancer Immunol Immunother 1978; 5: 211–216
   Web of Science ®Google Scholar
• Tzehoval E, Segal S, Stabinsky Y, Fridkin M, Spirer Z, Feldman M. Tuftsin (an Ig-associated tetrapeptide) triggers the immunogenic function of macrophages: Implications for activation of programmed cells. Proc Natl Acad Sci USA 1978; 75: 3400–3404
   PubMed Web of Science ®Google Scholar
• Luftig R B, Yoshinaka Y, Oroszlan S. Sequence relationship between Rauscher Leukemia virus (RLV) p 65-70 (gag gene product) and tuftsin as monitored by the p 65-70 proteolytic factor. J Cell Biol 1977; 25: 397a
   Google Scholar
• Oroszlan S, Henderson L W, Stephenson J R, Copeland T D, Long C W, Ihle J N, Gilden R V. Amino-and carboxy-terminal amino acid sequences of proteins coded by gag gene of murine leukemia virus. Proc Natl Acad Sci USA 1978; 75: 1404–1408
   PubMed Web of Science ®Google Scholar
• Bar-Shavit Z, Goldman R, Stabinsky Y, Gottlieb P, Fridkin M, Teichberg V I, Blumberg S. Enhancement of phagocytosis—A newly found activity of substance P residing in its N-terminal tetrapeptide sequence. Biochem Biophys Res Commun 1980; 94: 1445–1451
   PubMed Web of Science ®Google Scholar
• Bar-Shavit Z, Goldman R. Tuftsin and substance P as modulators of phagocyte functions. Adv Exp Med Biol 1982; 141: 549–558
   PubMed Web of Science ®Google Scholar
• Herman Z S, Stachura Z, Siemion I Z, Nawrocka E. Analgesic activity of tuftsin analogs. Naturwissenschaften 1980; 67: 613–614
   PubMed Web of Science ®Google Scholar
• Kamenskii A A, Antonova L V, Samoilova N A, Galkin O M, Andreev S M, Ashmarin I P. Excitatory action of the tetrapeptide tuftsin on activity of albino rats. Bull Exp Biol Med 1980; 89: 911–914
   Web of Science ®Google Scholar
• Val'dman A V, Kozlovskaya M M, Ashmarin I P, Mineeva M F, Anokhin K V. Central effects of the tetrapeptide tuftsin. Bull Exp Biol Med 1981; 92: 890–892
   Web of Science ®Google Scholar
• Nishioka K, Babcock G F, Phillips J H, Noyes R D. Antitumor effect of tuftsin. Mol Cell Biochem 1981; 41: 13–18
   PubMed Web of Science ®Google Scholar
• Takami H, Nishioka K. Raised polyamines in erythrocytes from melanoma-bearing mice and patients with solid tumours. Br J Cancer 1980; 41: 751–756
   PubMed Web of Science ®Google Scholar
• Nishioka K, Takami H, Noyes R D, Babcock G F. Cloudman S-91 melanoma colony assay in the lungs of mice and profiles of the biochemical tumor markers, tyrosinase and polyamines. Pigment Cell 1981, Phenotypic Expression in Pigment Cell, M Seiji. University of Tokyo Press, Tokyo 1981; 617–621
   Google Scholar
• Noyes R D, Babcock G F, Nishioka K. Antitumor activity of tuftsin on murine melanoma in vivo. Cancer Treat Rep 1981; 65: 673–675
   PubMedGoogle Scholar
• Babcock G F, Noyes R D, Nishioka K. The effect of tuftsin, an immunopotentiating peptide, on Cloudman S-91 melanoma in vivo. Pigment Cell 1981, Phenotypic Expression in Pigment Cell, M Seiji. University of Tokyo Press, Tokyo 1981; 623–628
   Google Scholar
• Nishioka K, Babcock G F, Phillips J H, Banks R A, Amoscato A A. In vivo and in vitro antitumor activities of tuftsin. Ann NY Acad Sci, in press
   Web of Science ®Google Scholar
• Banks R A, Babcock G F, Nishioka K. Effect of tuftsin on in vivo murine oncogenesis. Proc Am Assoc Cancer Res 1983; 24: 1994
   Google Scholar
• Babcock G F, Phillips J H, Nishioka K. The immunotherapeutic effect of the peptide tuftsin on the B cell lymphoma, CHI. B and T Cell Tumors: Biological and Clinical Aspects, E Vitetta, C F Fox. Academic Press, New York 1982; 481–485
   Google Scholar
• Catanzaro P J, Schwartz H J, Graham R C. Spectrum and possible mechanism of carrageenan cytotoxicity. Am J Pathol 1971; 64: 387–404
   PubMed Web of Science ®Google Scholar
• Quan P-C, Kolb J-P, Lespinats G. NK activity in carrageenantreated mice. Immunology 1980; 40: 495–503
   PubMed Web of Science ®Google Scholar
• Sunkara P S, Prakash N J, Nichioka K. Potentiation of antitumor activity of α-difluoromethyl ornithine by immunomodulating peptide tuftsin. Ann NY Acad Sci, in press
   Web of Science ®Google Scholar
• Metcalf B W, Bey P, Danzin C, Jung M J, Casara P, Vevert J P. Catalytic irreversible inhibition of mammalian ornithine decarboxylase (E.C. 4.1.1.17) by substrate and product analogues. J Am Chem Soc 1978; 100: 2551–2553
   Web of Science ®Google Scholar
• Nishioka K. In vitro induction of human granulocyte cytotoxicity by tuftsin. Gann 1979; 70: 845–846
   PubMedGoogle Scholar
• Phillips J H, Nishioka K, Babcock G F. Tuftsin-induced enhancement of murine and human natural cell-mediated cytotoxicity. Ann NY Acad Sci, in press
   Web of Science ®Google Scholar
• Bruley-Rosset M, Hercend T, Martinez J, Rappaport H, Mathe G. Prevention of spontaneous tumors of aged mice by immunopharmacologic manipulation: Study of immune antitumor mechanisms. J Natl Cancer Inst 1981; 66: 1113–1119
   PubMed Web of Science ®Google Scholar
• Bruley-Rosset M, Florentin I, Mathe G. Macrophage activation by tuftsin and muramy 1-dipeptide. Mol Cell Biochem 1981; 41: 113–118
   PubMed Web of Science ®Google Scholar
• Najjar V A, Konopinska D, Chaudhuri M K, Schmidt D E, Linehan Tuftsin L. a natural activator of phagocytic functions including tumoricidal activity. Mol Cell Biochem 1981; 41: 3, 12
   PubMed Web of Science ®Google Scholar
• Catane R, Schlanger S, Weiss L, Penchas S, Fuks Z, Treves A J, Fridkin M. Toxicology and antitumor activity of tuftsin. Ann NY Acad Sci, in press
   PubMedGoogle Scholar
• Mathe G, Bruley-Rosset M, Rappaport H. Spontaneous development of tumors in C57BL/6 mice associated with aging. Ann NY Acad Sci, in press
   Google Scholar